Filing Analysis
📢 Regulation FD Disclosure
Filed Jun 15, 2026
⚪ LOW
Nephros, Inc. filed an 8-K to report the publication of an updated 2026 Corporate Presentation on its website. The information was furnished under Item 7.01 and is not deemed 'filed' for liability purposes under Section 18 of the Exchange Act.
📋 Key Facts
- The company posted an updated 2026 Corporate Presentation on June 12, 2026.
- The presentation is attached as Exhibit 99.1.
- The filing was signed by Judy Krandel, Chief Financial Officer.
📢 Regulation FD Disclosure
Filed May 07, 2026
⚪ LOW
Nephros, Inc. announced its first quarter 2026 financial results via a press release on May 7, 2026. The filing is a standard quarterly update furnished under Item 2.02.
📋 Key Facts
- Reported Q1 2026 financial results on May 7, 2026.
- Information furnished under Item 2.02 (Results of Operations and Financial Condition).
- Included Exhibit 99.1, the official press release regarding financial performance.
📢 Regulation FD Disclosure
Filed Mar 27, 2026
⚪ LOW
Nephros, Inc. updated its 2026 Corporate Presentation on its website and furnished the presentation as an exhibit to this 8-K filing. This is a routine disclosure under Regulation FD to ensure all investors have access to the same company information.
📋 Key Facts
- The filing was made on March 27, 2026, under Item 7.01 Regulation FD Disclosure.
- The updated 2026 Corporate Presentation is included as Exhibit 99.1.
- The information is furnished and not deemed 'filed' for purposes of Section 18 of the Exchange Act.
- The report was signed by Judy Krandel, Chief Financial Officer.
Disclaimer: This analysis is generated by AI and is for informational purposes only.
It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities.
Always review the original SEC filings and consult a financial advisor before making investment decisions.